Physician profile
Barry I Auster
NPI 1255323341
$3,248.08
in general payments reported to CMS, 2019-2025
22 companies · $39.19 in 2025
The $39.19 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,697 · 2020: $233 · 2021: $279 · 2025: $39.19.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $39.19.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $39.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $1,330.00 | 2019 | |
| Janssen Biotech, INC. | $389.88 | 2019-2025 | Tremfya |
| Abbvie INC. | $234.40 | 2019-2021 | |
| Merz North America, INC. | $223.21 | 2019 | |
| Novartis Pharmaceuticals Corporation | $174.67 | 2019-2021 | |
| Genzyme Corporation | $124.51 | 2019-2021 | |
| Janssen Scientific Affairs, LLC | $118.58 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $111.05 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $82.30 | 2019-2021 | |
| Lilly USA, LLC | $82.01 | 2019-2021 | |
| Pfizer INC. | $67.86 | 2019-2021 | |
| Epi Health, LLC | $58.16 | 2019 | |
| Galderma Laboratories, L.P. | $43.74 | 2019-2020 | |
| Aclaris Therapeutics, INC. | $43.53 | 2019 | |
| Helsinn Therapeutics (U.S.), INC. | $26.90 | 2019-2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $26.32 | 2019 | |
| Boston Scientific Corporation | $25.25 | 2025 | General - Pain Management |
| E.R. Squibb & Sons, L.L.C. | $24.29 | 2021 | |
| Dusa Pharmaceuticals, INC. | $17.70 | 2019 | |
| Smith+Nephew, INC. | $15.94 | 2019 | |
| Sun Pharmaceutical Industries INC. | $15.49 | 2019 | |
| Strata Skin Sciences, INC. | $12.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barry Auster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.